The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond (Q38820260)

6 September 2017

The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond (English)

1 reference

6 September 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rosa Fernandes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

A L João

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

29 April 2016

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

553-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives

4 June 2020

cites work

1 reference

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

21 January 2018

1 reference

The biology of incretin hormones

21 January 2018

1 reference

The role of incretin therapy at different stages of diabetes

21 January 2018

1 reference

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?

21 January 2018

1 reference

The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.

21 January 2018

1 reference

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

21 January 2018

1 reference

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential

21 January 2018

1 reference

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

The importance of weight management in type 2 diabetes mellitus.

21 January 2018

1 reference

Diabetes remission after bariatric surgery: is it just the incretins?

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

21 January 2018

1 reference

Physiology of weight loss surgery

21 January 2018

1 reference

Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets

21 January 2018

1 reference

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes

21 January 2018

1 reference

Inflammasome is a central player in the induction of obesity and insulin resistance

21 January 2018

1 reference

The [pre-] history of the incretin concept

21 January 2018

1 reference

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

GIP and GLP-1, the two incretin hormones: Similarities and differences

21 January 2018

1 reference

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

Do incretins improve endothelial function?

21 January 2018

1 reference

Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease

21 January 2018

1 reference

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 January 2018

1 reference

Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP.

21 January 2018

1 reference

Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease.

21 January 2018

1 reference

Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials

21 January 2018

1 reference

Prevention of obesity-induced renal injury in male mice by DPP4 inhibition

21 January 2018

1 reference

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome

21 January 2018

1 reference

The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.

21 January 2018

1 reference

Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors

21 January 2018

1 reference

Adenosine: an endogenous regulator of innate immunity

21 January 2018

1 reference

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

21 January 2018

1 reference

The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes

21 January 2018

1 reference

Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.

21 January 2018

1 reference

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

21 January 2018

1 reference

Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals

21 January 2018

1 reference

Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells.

21 January 2018

1 reference

Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties

21 January 2018

1 reference

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.

21 January 2018

1 reference

A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin based therapy

21 January 2018

1 reference

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes

21 January 2018

1 reference

Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)

21 January 2018

1 reference

Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

21 January 2018

1 reference

Gut peptides and the regulation of appetite.

21 January 2018

1 reference

Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.

21 January 2018

1 reference

Monosodium Glutamate Dietary Consumption Decreases Pancreatic β-Cell Mass in Adult Wistar Rats

21 January 2018

1 reference

GLP-1 based therapeutics: simultaneously combating T2DM and obesity.

21 January 2018

1 reference

The central GLP-1: implications for food and drug reward

21 January 2018

1 reference

Is the GLP-1 system a viable therapeutic target for weight reduction?

21 January 2018

1 reference

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

21 January 2018

1 reference

CNS GLP-1 regulation of peripheral glucose homeostasis

21 January 2018

1 reference

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

Effects of GLP-1 on appetite and weight

21 January 2018

1 reference

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity

21 January 2018

1 reference

The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review

21 January 2018

1 reference

Ghrelin Is a Novel Regulator of GLP-1 Secretion

21 January 2018

1 reference

Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling

21 January 2018

1 reference

Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats

21 January 2018

1 reference

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

21 January 2018

1 reference

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

Role of leptin in the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis

21 January 2018

1 reference

Circadian secretion of the intestinal hormone GLP-1 by the rodent L cell.

21 January 2018

1 reference

Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation

21 January 2018

1 reference

The future role of gut hormones in the treatment of obesity

21 January 2018

1 reference

Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?

21 January 2018

1 reference

The omentum: anatomical, metabolic, and surgical aspects.

21 January 2018

1 reference

Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.

21 January 2018

1 reference

Insulin resistance and cancer: the role of insulin and IGFs

21 January 2018

1 reference

Leptin as a link between the immune system and kidney-related diseases: leading actor or just a coadjuvant?

21 January 2018

1 reference

A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?

21 January 2018

1 reference

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

21 January 2018

1 reference

From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes.

21 January 2018

1 reference

A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation

21 January 2018

1 reference

The complex immunological and inflammatory network of adipose tissue in obesity

21 January 2018

1 reference

Immune adaptations that maintain homeostasis with the intestinal microbiota

21 January 2018

1 reference

Physiology and pathophysiology of incretins in the kidney

21 January 2018

1 reference

DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue

21 January 2018

1 reference

Pharmacotherapy for the management of obesity

21 January 2018

1 reference

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study

21 January 2018

1 reference

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

21 January 2018

1 reference

Mechanisms of incretin effects on plasma lipids and implications for the cardiovascular system

21 January 2018

1 reference

Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression.

21 January 2018

1 reference

Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function

21 January 2018

1 reference

Conditioned taste aversion as a learning and memory paradigm.

21 January 2018

1 reference

Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes

21 January 2018

1 reference

Immunization against active ghrelin using virus-like particles for obesity treatment

21 January 2018

1 reference

Incretin-based therapies for obesity treatment

21 January 2018

1 reference

The dipeptidyl peptidase-4 inhibitor des-fluoro-sitagliptin regulates brown adipose tissue uncoupling protein levels in mice with diet-induced obesity

21 January 2018

1 reference

Brown adipose tissue in adult humans: a metabolic renaissance

21 January 2018

1 reference

The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.

21 January 2018

1 reference

DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

21 January 2018

1 reference

Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans

21 January 2018

1 reference

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

21 January 2018

1 reference

Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.

21 January 2018

1 reference

CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice

21 January 2018

1 reference

Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha

21 January 2018

1 reference

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

21 January 2018

1 reference

Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

21 January 2018

1 reference

SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury

21 January 2018

1 reference

CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.

21 January 2018

1 reference

The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.

21 January 2018

1 reference

The impact of bariatric surgery on quality of life: a systematic review and meta-analysis.

21 January 2018

1 reference

Detailed characterization of incretin cell distribution along the human small intestine.

21 January 2018

1 reference

Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile

21 January 2018

1 reference

GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats

21 January 2018

1 reference

Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery

21 January 2018

1 reference

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

21 January 2018

1 reference

Are bile acids the new gut hormones? Lessons from weight loss surgery models

21 January 2018

1 reference

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

21 January 2018

1 reference

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

21 January 2018

1 reference

Appetite and body weight regulation after bariatric surgery

21 January 2018

1 reference

The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain

21 January 2018

1 reference

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

Bile acid sequestrants: more than simple resins

21 January 2018

1 reference

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

21 January 2018

1 reference

An updated review on cancer risk associated with incretin mimetics and enhancers

21 January 2018

1 reference

Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.

21 January 2018

1 reference

MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice

21 January 2018

1 reference

Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats

21 January 2018

1 reference

Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity

21 January 2018

1 reference

Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats.

21 January 2018

1 reference

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat

21 January 2018

1 reference

Reduced Incretin Effect in Type 2 Diabetes

21 January 2018

1 reference

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

A comprehensive review on metabolic syndrome

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1155/2014/943162

12 January 2024

Identifiers

DOI

10.1111/OBR.12421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125902%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference